Imaging of the Glucose-Dependent Insulinotropic Polypeptide Receptor Using a Novel Radiolabeled Peptide Rationally Designed Based on Endogenous GIP and Synthetic Exendin-4 Sequences
Imaging and radiotherapy targeting the glucose-dependent insulinotropic polypeptide receptor (GIPR) could potentially benefit the management of neuroendocrine neoplasms (NENs), complementing clinically established radiopharmaceuticals. The aim of this study was to evaluate a GIPR-targeting positron...
Saved in:
Main Authors: | Irina Velikyan (Author), Martin Bossart (Author), Torsten Haack (Author), Iina Laitinen (Author), Sergio Estrada (Author), Lars Johansson (Author), Stefan Pierrou (Author), Michael Wagner (Author), Olof Eriksson (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Automated GMP-Compliant Production of [<sup>68</sup>Ga]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans
by: Michael Wagner, et al.
Published: (2020) -
Attenuated secretion of glucose-dependent insulinotropic polypeptide (GIP) does not alleviate hyperphagic obesity and insulin resistance in ob/ob mice
by: Satoko Shimazu-Kuwahara, et al.
Published: (2017) -
Molecular mechanism of an antagonistic antibody against glucose-dependent insulinotropic polypeptide receptor
by: Xiaoshan Min, et al.
Published: (2020) -
Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
by: Belinda Trachsel, et al.
Published: (2023) -
Serum and expression profiles of glucose-dependent insulinotropic polypeptide in correlation with cardiometabolic risk factors among patients with systemic lupus erythematosus
by: Nearmeen M Rashad, et al.
Published: (2019)